首页 | 本学科首页   官方微博 | 高级检索  
检索        

泮托拉唑治疗2型糖尿病合并胃溃疡临床评价
引用本文:杨静.泮托拉唑治疗2型糖尿病合并胃溃疡临床评价[J].糖尿病新世界,2020(9):58-59,62.
作者姓名:杨静
作者单位:黑龙江省农垦红兴隆管理局中心医院消化内科
摘    要:目的研究2型糖尿病合并胃溃疡采用泮托拉唑治疗的临床价值。方法选择该院接收的66例2型糖尿病合并胃溃疡患者,采纳随机数字表法分观察组(泮托拉唑)与对照组(奥美拉唑)各33例,比较两组血糖指标与临床疗效。结果治疗前两组血糖指标差异无统计学意义(P>0.05);治疗后与对照组比较,观察组空腹血糖与餐后2 h血糖较低;治疗有效率较高,观察组不良反应发生率(6.06%)低于对照组24.24%(P<0.05)。结论泮托拉唑治疗2型糖尿病合并胃溃疡能提高整体疗效,便于控制疾病进展。

关 键 词:2型糖尿病  胃溃疡  泮托拉唑

Clinical Evaluation of Pantoprazole in the Treatment of Type 2 Diabetes with Gastric Ulcer
YANG Jing.Clinical Evaluation of Pantoprazole in the Treatment of Type 2 Diabetes with Gastric Ulcer[J].Diabetes New World,2020(9):58-59,62.
Authors:YANG Jing
Institution:(Department of Gastroenterology,Central Hospital of Heilongjiang Provincial Agricultural Reclamation Hongxinglong Administration Bureau,Shuangyashan,Heilongjiang Province,155811 China)
Abstract:Objective To study the clinical value of pantoprazole in the treatment of type 2 diabetes with gastric ulcer.Methods A total of 66 patients with type 2 diabetes and gastric ulcer received in the hospital were selected.The random number table was used to divide observation group(pantoprazole)and control group(omeprazole)into 33 cases each.Clinical efficacy of the two groups were compared.Results There was no statistically significant difference in blood glucose indexes before treatment in the two groups(P>0.05);compared with the control group after treatment,the fasting blood glucose in the observation group was lower than in 2 h after meals and higher in effective rate;the adverse reaction rate(6.06%)was lower than the control group 24.24%(P<0.05).Conclusion Pantoprazole in the treatment of type 2 diabetes with gastric ulcer can improve the overall efficacy and facilitate the control of disease progression.
Keywords:Type 2 diabetes  Gastric ulcer  Pantoprazole
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号